Spectrum Brands Holdings Inc. SPB
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Business Model#
What the company does and how it earns its money; written AI-editorially, exclusively from the company's original reports, without any assessment of our own.
Spectrum Brands Holdings is a consumer products company that designs, manufactures, and markets branded products across three reportable segments: Global Pet Care (GPC), Home & Garden (H&G), and Home & Personal Care (HPC). GPC supplies pet food, treats, grooming products, and habitat accessories sold through pet specialty and mass retail channels; H&G offers pest control, lawn care, and garden products with concentrated seasonal demand; HPC produces personal care appliances and home improvement tools distributed through mass retail and e-commerce platforms across North America, EMEA, and other international markets. Revenue is generated through sales to large retail chains, club stores, e-commerce platforms, and specialty retailers. The company earns margin through brand pricing power, product mix management, and supply chain efficiency. A 2026 strategic investment by Oaktree Capital in the HPC segment is oriented toward a longer-term pure-play structure centered on the GPC and H&G businesses.
Current Status#
Summary of the most recent reporting period: core figures, drivers and management statements; written editorially from the current original report, every figure backed by a source number.
Price & Chart#
Interactive price chart (TradingView) and the trend of key figures from the core tables. The price chart loads only after a click; at that point a connection to TradingView is established.
Daily candles with news and earnings markers. Loads only on click.
Share-Price Drivers#
Factors the company itself names as material for its business development (IR-based); reproduced neutrally, no price forecast and no assessment of our own.
The HPC partnership with Oaktree closed in May 2026 (HPC Term Loan and Oaktree investment recorded 2026-05-11) and reshapes the portfolio around the higher-growth Pet Care and Home & Garden businesses; HPC is still the largest revenue line at 321.5 (2026-Q1) yet is declining -7.6% 26 28 29.
GPC revenue 281.6 in 2026-Q1, up 8.3% with a 17.4% margin; supported by premium shelf placement regained in the chews category and new points of distribution (July 2025) plus GoodBoy brand expansion 26 22 27.
HPC revenue 321.5 in 2026-Q1, down -7.6% with a 6.4% margin; segment is undergoing strategic separation via the Oaktree partnership 26 27 28.
H&G revenue 73.9 in 2026-Q1, down -19.8% with a 6.1% margin; FY2025 H&G revenue 572.8 was down -1.0% 26 24.
Tariff pricing implementation with major customers launched Q3 2025 alongside supply-chain diversification away from China 22.
Multi-phase SAP S/4 HANA ERP rollout planned through calendar year 2026, beginning with Global Pet Care and Home & Garden 26 28 18.
$300 million share repurchase authorization and continued debt refinancing; net debt eased to 356.9 in 2026-Q3 from 544.6 a year earlier 26 130 122.
Sector trend: Segment KPIs are diverging: Pet Care demand is accelerating with double-digit growth and a ~17% margin, while Home & Personal Care and Home & Garden demand is contracting on low-single-digit margins. Group adjusted EPS strengthened to 2.79 in 2026-Q3 and guidance was raised, though reported net income was negative at -26.8 26 130.
Event Timeline#
This timeline collects the material events from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements. Events are grouped by quarter (most recent first); the grey tag before each event names the event type, the date is the publication date of the source. Management quotes open the quarter block as direct quotes. Per quarter we show the three most defining events; more can be expanded per quarter, older years are collapsed. Every event carries its source as a superscript, clickable number.
2026 · 10 events
2026-Q3 · Apr – Jun 2026
Adjusted EBITDA increased 106.7% to $158.3M (21.0% margin) from $76.6M (10.9%) in prior year, including $60.6M one-time IEEPA tariff refunds following a court ruling on their unlawfulness; higher volumes and pricing also contributed to the underlying improvement 29
$104.0M impairment charge on HPC indefinite-lived intangible assets, triggered by valuation change associated with Oaktree investment, drove Q3 net loss of $26.8M 29
Net sales increased 7.7% to $753.3M; organic growth of 6.6%, with Home & Garden achieving a record-setting quarter (+19.0% net sales) driven by favorable weather and above-market performance 29
2026-Q2 · Jan – Mar 2026
Net sales increased 4.9% to $708.9M; organic growth of 1.5%, first top-line growth since Q1 fiscal 2025, led by Global Pet Care (+7.6% organic) and Home & Garden (+11.2% organic) 28
FY2026 adjusted EBITDA expectation raised to low to mid single-digit growth from prior flat to low single-digit guidance; net sales guidance maintained at flat to low single-digit growth 28
Oaktree Capital Management executed $127M investment in Home & Personal Care business via preferred equity and debt, with Oaktree acquiring 24.9% equity; Spectrum Brands retained approximately 73% ownership of the Appliances business 28
Operating income more than doubled YoY (19.5 to 43.5 USDm, +123%). 128
2026-Q1 · Oct – Dec 2025
Consolidated net sales declined 3.3% to $677.0M; organic net sales down 6.0%, driven by volume declines in H&G (-19.8% organic) and HPC (-11.1% organic), partially offset by GPC organic growth of 5.8% 25
Adjusted EBITDA margin compressed 200 basis points to 9.2% from 11.1%, driven by lower volumes, higher tariff and inflationary costs, and unfavorable mix 25
FY2026 framework reiterated at flat to low single-digit net sales growth and low single-digit adjusted EBITDA growth 26
2025 · 17 events
2025-Q4 · Jul – Sep 2025
Company announced plan to divest the Home and Personal Care business through sale or spin-off to create two distinct publicly traded companies 24
Net sales decreased 5.2% in Q4, organic -6.6%, primarily due to supply constraints from halting Chinese imports and category softness across Global Pet Care and Home and Personal Care 23
Gross profit margin decreased 220 basis points to 35.0% from 37.2% due to lower volume, unfavorable mix, inflation and tariffs, partially offset by pricing and cost improvements 23
Operating cash flow reached 171.1 USDm vs 80.7 USDm in 2024-Q4 (×2.1). 123
Operating cash flow turned positive on a half-year basis (2025-H1: -49.3 to 2025-H2: +252.9 USDm, aggregated from reported quarters where needed). 123
2025-Q3 · Apr – Jun 2025
Net sales decreased 10.2% to $699.6M, organic -11.1%, driven by tariff-related supply constraints, stop shipments during pricing negotiations, and demand softness in Global Pet Care and Home and Personal Care 22
Adjusted EBITDA margin decreased 270 basis points to 10.9% from 13.6%, reflecting lower operating volumes and reduced investment income 22
Reaffirmed expectation to generate approximately $160M of free cash flow in fiscal 2025 while continuing to suspend the broader earnings framework due to global trade and tariff uncertainty 22
2025-Q2 · Jan – Mar 2025
Net sales decreased 6.0% to $675.7M driven by volume declines across all segments from softening North American demand, tariff pressure, and unfavorable foreign currency impacts 19
Suspended FY2025 earnings framework due to uncertainty caused by global trade conditions, tariffs, and associated softening of global consumer demand 20
Pivoted operating strategy to maximize cash; temporarily paused finished goods imports from China and accelerated supply chain diversification outside China for U.S. market across all three segments 20
Operating income more than halved YoY (75.9 to 19.5 USDm, -74%). 128
2025-Q1 · Oct – Dec 2024
Net sales increased 1.2% to $700.2M, organic +1.9%, driven by extended fall season and accelerated pre-season sales in Home & Garden segment 17
Gross profit margin improved 140 basis points to 36.8%, driven by volume growth and cost improvements, partially offset by ocean freight inflation and higher tariffs 17
Maintained FY2025 earnings framework with low single-digit net sales growth and mid-to-high single-digit adjusted EBITDA growth, targeting approximately 50% conversion of adjusted EBITDA to adjusted free cash flow 18
2024 · 15 events
FY2024 · Oct 2023 – Sep 2024
Operating income turned positive for the first time after 1 negative fiscal year (-205.6 to +170.6 USDm). 116
2024-Q4 · Jul – Sep 2024
Q4 net sales increased 4.5% with organic net sales increase of 4.8%, driven by higher volumes across all segments including retailer pull forward in Global Pet Care for ERP implementation, favorable weather in Home & Garden, and global growth in Home & Personal Care 16
Fiscal 2025 guidance initiated: low single-digit net sales growth, mid to high single-digit adjusted EBITDA growth, and adjusted free cash flow targeting approximately 50% conversion of adjusted EBITDA 16
Returned $482.7 million to shareholders through share repurchases in fiscal 2024 and increased quarterly dividend 12% to $0.47 per share; ended fiscal year with net debt leverage of 0.56x adjusted EBITDA and $402.7 million remaining under repurchase authorization 16
2024-Q3 · Apr – Jun 2024
Net sales increased 6.0% to $779.4 million driven by organic growth of 7.1%, with favorable weather in Home & Garden and improved retailer inventory health 14
Full year adjusted EBITDA growth guidance raised to approximately 20% from prior low double-digit expectation; net sales outlook maintained at relatively flat 14
Home and Personal Care business launched multi-track process pursuing sale, merger, or spin-off; filed initial Form 10 registration statement with SEC 14
2024-Q2 · Jan – Mar 2024
Gross profit margin improved 870 bps to 38.1% due to lower cost inventory (prior-year high-cost inventory base effect), favorable mix, and cost improvements 12
Updated fiscal 2024 earnings framework expecting net sales to be relatively flat and adjusted EBITDA to grow low double-digits 12
Continuing to pursue strategic alternative for Home & Personal Care business via sale, joint venture or spin later in 2024; entered new long-term Black & Decker license agreement through end of calendar 2035 12
2024-Q1 · Oct – Dec 2023
Adjusted EBITDA increased 111.8% to $84.3 million, margin expanding to 12.2% from 5.6%, driven by improved cost structure and manufacturing efficiencies 9
Net income from continuing operations improved to $17.5 million from a loss of $40.0 million, an increase of $57.5 million 10
Gross profit margin expanded 710 bps to 35.4%, driven by lower cost inventory vs. prior year (prior-year high-cost inventory base effect) and favorable product and channel mix 9
2023 · 17 events
2023-Q4 · Jul – Sep 2023
Operating income turned positive for the first time after 3 negative periods (-124.7 to +16.3 USDm). 116
Q4 adjusted EBITDA of $113.7 million; adjusted diluted EPS increased 183.3% reflecting higher adjusted EBITDA, lower interest expense following debt repayment, and lower share count from buybacks 7
Margin structure improved through cost improvements and planned exit of non-core unproductive categories; adjusted EBITDA increased $39.0 million driven by gross profit improvements and interest income 7
Company issued FY2024 outlook: low single-digit net sales decline and high single-digit adjusted EBITDA growth, targeting long-term net leverage ratio of 2.0-2.5x 7
2023-Q3 · Apr – Jun 2023
Adjusted EBITDA from continuing operations increased 23% year over year to $98.5 million, including $5.3 million of investment income on post-divestiture cash balances 6
Repaid $1.55 billion of outstanding debt using HHI proceeds; ended Q3 with $2.9 billion cash and $2.1 billion debt outstanding, reaching a net cash position 6
Hardware and Home Improvement segment divestiture to ASSA ABLOY AB completed June 20, 2023 for $4.3 billion cash proceeds, recognizing gain on sale of $2,824.9 million 5
Net income turned positive for the first time after 2 negative periods (-53.6 to +1859.2 USDm). 114
2023-Q2 · Jan – Mar 2023
Net sales decreased 9.7% to $729.2M driven by retailer inventory reduction strategy, lower replenishment orders, slower point-of-sale, and unfavorable foreign currency 3
FY2023 outlook revised to mid single-digit net sales decline and low-to-mid single-digit adjusted EBITDA decline, from prior framework of flat sales and low double-digit EBITDA growth 4
DOJ lawsuit resolved via settlement requiring ASSA ABLOY to divest Emtek and Smart Residential Business; HHI divestiture expected to close no later than June 30, 2023 3 4
Operating cash flow reached 241.8 USDm vs 64.2 USDm in 2022-Q2 (×3.8). 104
2023-Q1 · Oct – Dec 2022
Net sales fell 5.8% to $713.3M driven by lower replenishment orders, slower holiday retail sales, high retail inventory levels, and unfavorable foreign currency across all segments 1
FY2023 earnings framework updated: net sales expected flat to prior year with low double-digit adjusted EBITDA growth maintained 2
HHI divestiture anticipated to close no later than June 2023 with expected cash proceeds of $4.3 billion 2
Key Figures ($m)#
The company's core financial figures in three views, one below the other: fiscal years (as reported; after restatements the table shows the most recent filing version, marked), half-years (6-month basis, H2 = second half on its own) and quarters (3-month basis, not cumulative). Each row is one period, most recent first. Values with a dotted underline are clickable and show the raw value, the exact source location, the scale evidence and the source; derived values additionally show their formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Calendar quarter | Revenue | Op. income | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | OCF | Source |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Q4/2024–Q3/2025 | 2,809 | 124.9 | 99.9 | 3.86 | 5.55 | 289.1 | 203.6 | 123 |
| FY2024 | Q4/2023–Q3/2024 | 2,963.9 | 170.6 | 124.8 | 4.10 | 4.13 | 371.8 | 162.6 | 116 |
| FY2023 | Q4/2022–Q3/2023 | 2,918.8 | -205.6 | 1,801.5 | 45.65 | 1.59 | 303.6 | -409.7 | 107 |
Quarters
| Period | Calendar quarter | Published | Revenue | Op. income | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | FCF | Cash | Net Debt | Net Debt/EBITDA (x) | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q3* | Q2/2026 | 2026-08-07 | 753.3 | 15.9 | -26.8 | -1.16 | 2.79 | 158.3 | 73.5 | 258.9 | 356.9 | 1.7x (LTM) | 130 |
| 2026-Q2* | Q1/2026 | 2026-05-07 | 708.9 | 43.5 | 22.1 | 0.94 | 1.25 | 84 | 0.9 | 125.1 | 462.8 | 2x (LTM) | 128 |
| 2026-Q1* | Q4/2025 | 2026-02-05 | 677 | 27.1 | 28.4 | 1.21 | 1.40 | 62.6 | 59.3 | 126.6 | 439.6 | 2.1x (LTM) | 126 |
| 2025-Q4* | Q3/2025 | 2025-11-13 | 733.5 | 29.4 | 55.7 | 2.29 | 2.61 | 63.4 | 157.9 | 123.6 | 444.3 | 2x (LTM) | 123 |
| 2025-Q3* | Q2/2025 | 2025-08-07 | 699.6 | 31.3 | 19.9 | 0.80 | 1.24 | 76.6 | 71.8 | 122 | 544.6 | 2.5x (LTM) | 122 |
| 2025-Q2* | Q1/2025 | 2025-05-08 | 675.7 | 19.5 | 1.2 | 0.03 | 0.68 | 71.3 | 13.9 | 96 | 545.5 | 2.3x (LTM) | 19 |
| 2025-Q1* | Q4/2024 | 2025-02-06 | 700.2 | 44.7 | 23.8 | 0.84 | 1.02 | 77.8 | -78.3 | 179.9 | 378.9 | 1.3x (LTM) | 118 |
| 2024-Q4* | Q3/2024 | 2024-11-15 | 773.7 | 22 | 28.7 | 1.01 | 0.97 | 68.9 | 67.7 | 368.9 | 191.9 | 0.7x (LTM) | 15 |
| 2024-Q3* | Q2/2024 | 2024-08-08 | 779.4 | 47.7 | 6 | 0.21 | 1.13 | 106.3 | – | 157.7 | 402.8 | – | 114 |
| 2024-Q2* | Q1/2024 | 2024-05-09 | 718.5 | 75.9 | 60.9 | 2.01 | 1.40 | 112.3 | – | 745.7 | 637.7 | – | 112 |
| 2024-Q1* | Q4/2023 | 2024-02-08 | 692.2 | 25 | 29.2 | 0.85 | 0.63 | 84.3 | -12.7 | 445.4 | 951.2 | – | 9 |
| 2023-Q4* | Q3/2023 | 2024-11-15 | 740.7 | 16.3 | 16.4 | 0.47 | 1.12 | 111.5 | – | 753.9 | 801.6 | – | 116 |
| 2023-Q3* | Q2/2023 | 2023-08-11 | 735.5 | -124.7 | 1,859.2 | 46.07 | 0.93 | 98.5 | – | 2,930.2 | -851.8 | – | 5 |
| 2023-Q2* | Q1/2023 | 2023-05-12 | 729.2 | -77 | -53.6 | -1.31 | -0.14 | 51 | – | 327.8 | 2,860.9 | – | 104 |
| 2023-Q1* | Q4/2022 | 2023-02-10 | 713.3 | -20.2 | -20.9 | -0.51 | -0.32 | 39.8 | -74.2 | 228 | 3,052.2 | – | 1 |
Balance Sheet & Cash Flow ($m)#
Point-in-time balance sheet items (e.g. cash, financial debt) and cash flow items (operating cash flow, investments/capex) per fiscal year, half-year and quarter. Balance sheet values are as of the period end, flow items cover the period. Derived values are marked and are calculated, for example, as: net debt = financial debt − cash; free cash flow = operating cash flow − capex; the click popover shows formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
Fiscal years
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Q4/2024–Q3/2025 | 2025-11-13 | 123.6 | 567.9 | 444.3 | 98 | 203.6 | 38.3 | 165.3 | 123 |
| FY2024 | Q4/2023–Q3/2024 | 2024-11-15 | 368.9 | 560.8 | 191.9 | 101.8 | 162.6 | 44 | 118.6 | 116 |
| FY2023 | Q4/2022–Q3/2023 | 2023-11-21 | 753.9 | 1,555.5 | 801.6 | 91.2 | -409.7 | 59 | -468.7 | 8 |
Quarters
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q3 | Q2/2026 | 2026-08-07 | 258.9 | 615.8 | 356.9 | 24.8 | 83.3 | 9.8 | 73.5 | 130 |
| 2026-Q2 | Q1/2026 | 2026-05-07 | 125.1 | 587.9 | 462.8 | 24.2 | 10.2 | 9.3 | 0.9 | 128 |
| 2026-Q1 | Q4/2025 | 2026-02-05 | 126.6 | 566.2 | 439.6 | 25.8 | 67.4 | 8.1 | 59.3 | 126 |
| 2025-Q4 | Q3/2025 | 2025-11-13 | 123.6 | 567.9 | 444.3 | 23.9 | 171.1 | 13.2 | 157.9 | 123 |
| 2025-Q3 | Q2/2025 | 2025-08-07 | 122 | 666.6 | 544.6 | 25.1 | 81.8 | 10 | 71.8 | 122 |
| 2025-Q2 | Q1/2025 | 2025-05-08 | 96 | 641.5 | 545.5 | 24.5 | 23.1 | 9.2 | 13.9 | 19 |
| 2025-Q1 | Q4/2024 | 2025-02-06 | 179.9 | 558.8 | 378.9 | 24.5 | -72.4 | 5.9 | -78.3 | 118 |
| 2024-Q4 | Q3/2024 | 2024-11-15 | 368.9 | 560.8 | 191.9 | 25.5 | 80.7 | 13 | 67.7 | 15 |
| 2024-Q3 | Q2/2024 | 2024-08-08 | 157.7 | 560.5 | 402.8 | 25.2 | 82.7 | 10.1 | – | 114 |
| 2024-Q2 | Q1/2024 | 2024-05-09 | 745.7 | 1,383.4 | 637.7 | 25.4 | 3.5 | 12.5 | – | 112 |
| 2024-Q1 | Q4/2023 | 2024-02-08 | 445.4 | 1,396.6 | 951.2 | 25.5 | -4.3 | 8.4 | -12.7 | 9 |
| 2023-Q4 | Q3/2023 | 2024-11-15 | 753.9 | 1,555.5 | 801.6 | 23.6 | -514 | – | – | 116 |
| 2023-Q3 | Q2/2023 | 2023-08-11 | 2,930.2 | 2,078.4 | -851.8 | 22.6 | -73.3 | – | – | 5 |
| 2023-Q2 | Q1/2023 | 2023-05-12 | 327.8 | 3,188.7 | 2,860.9 | 22.4 | 241.8 | 15.9 | – | 104 |
| 2023-Q1 | Q4/2022 | 2023-02-10 | 228 | 3,280.2 | 3,052.2 | 22.6 | -64.2 | 10 | -74.2 | 1 |
Revenue by Type (as of 2026-Q3 · USDm · 5/6)#
Revenue split by segment or product type, exactly as the company itself reports it. The basis is stated next to each value (3, 6 or 12 months); segment totals can deviate from group revenue (reconciliation/consolidation items). If the company changes its segment structure, older structures are kept in the expandable part. Rows in grey are no longer reported separately by the company; they show the last available figures and are never extrapolated.
| Segment | Since | Period | Basis | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|---|---|
| Home & Garden | 2025-Q2 | 2026-Q2 | 6M | 243.4 | -0.4% | 16.1% | 27 |
| H&G | 2023-Q1 | FY2025 | 12M | 572.8 | -1% | – | 24 |
| Home & Personal Care (HPC) | 2022-Q1 | 2026-Q1 | 3M | 321.5 | -7.6% | 6.4% | 26 |
| Global Pet Care (GPC) | 2022-Q1 | 2026-Q1 | 3M | 281.6 | 8.3% | 17.4% | 26 |
| Home & Garden (H&G) | 2022-Q1 | 2026-Q1 | 3M | 73.9 | -19.8% | 6.1% | 26 |
| Home and Garden | 2023-Q2 | 2024-Q1 | 3M | 72 | 0.8% | -1% | 9 |
Products & M&A (9/11 active+recent)#
Product announcements from the reports; market launches, approvals, partnerships; with first mention (date) and source. “Active/current” means: still mentioned in the most recent reports; what the company no longer mentions moves to the expandable part but is never deleted. Rows in grey are discontinued products.
| Product/Line | Since | Status | Source |
|---|---|---|---|
| GoodBoy® brand expansion | 2026-06 | Launched | 27 |
| $300 Million Share Repurchase Authorization | 2026 | Launched | 26 |
| Tariff pricing implementation with major customers | 2025-09 | Launched | 22 |
| Supply chain diversification away from China | 2025-09 | Launched | 22 |
| Premium shelf placement regained in chews category | 2025-07 | Launched | 22 |
| New points of distribution in Global Pet Care | 2025-07 | Launched | 22 |
| S/4Hana ERP Implementation - Home & Garden | 2025-06 | Launched | 18 |
| S/4Hana ERP Implementation - Global Pet Care | 2025-03 | Launched | 18 |
| SAP S/4 HANA ERP deployment (6x) | 2024-06 | Launched | 28 |
| Debt repurchase and refinancing | 2024-03 | Launched | 11 |
| Share repurchase plan (Rule 10b5-1) | 2023-12 | Launched | 11 |
M&A (34)#
All recorded acquisitions (purchases) and divestitures/exits with date, short description and source; deliberately including smaller transactions that summaries often miss. Purchase prices appear only where the company itself has disclosed them. Rows in grey are cancelled transactions; the cancellation date is shown in the row.
Acquisitions
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| Deferred HPC Preferred Equity purchase completion | 2026-07 | Completed | 29 |
| Oaktree Capital investment in HPC business | 2026-05 | Completed | 29 |
| Oaktree Capital partnership on Home & Personal Care Business | 2026-05 | Announced | 28 |
| Repayment of $1.174 billion senior unsecured bonds | 2024-06 | Completed | 14 |
| New Black & Decker License Agreement | 2024-05 | Announced | 12 |
| Exchangeable Notes Issuance (3x) | 2024-05 | Completed | 14 |
| Tender offer on Senior Notes | 2024 | Completed | 13 |
| HPC segment separation (9x) | 2023-06 | Completed | 20 |
| Tristar Business acquisition (PowerXL, Emeril, Copper Chef brands) | 2022-02 | Completed | 8 |
| Rejuvenate acquisition (9x) | 2021-05 | Completed | 15 |
| Armitage Pet Care Ltd acquisition (Good Boy, Meowee, Wildbird brands) | 2020-10 | Completed | 8 |
| Armitage Acquisition (2x) | 2020-10 | Completed | 5 |
| Omega Sea LLC acquisition (Omega brand premium fish foods) | 2020-03 | Completed | 8 |
| Omega Acquisition (2x) | 2020-03 | Completed | 5 |
Divestitures / exits
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| HHI separation | 2025-06 | Divested | 24 |
| HPC Business strategic alternative (sale, joint venture or spin) | 2024-06 | Divested | 12 |
| Creation of Global Pet Care and Home & Garden pure-play company | 2024-03 | Divested | 10 |
| Exit of non-strategic categories in Global Pet Care | 2023-12 | Divested | 7 |
| HHI divestiture completion | 2023-09 | Divested | 8 |
| Hardware and Home Improvement segment divestiture to ASSA ABLOY AB | 2023-06 | Divested | 8 |
| HHI segment divestiture to ASSA | 2023-06 | Divested | 8 |
| HHI segment divestiture | 2023-06 | Divested | 13 |
| HHI sale to ASSA ABLOY | 2023-06 | Divested | 4 |
| HHI Divestiture | 2023-06 | Divested | 20 |
| HHI Business Divestiture | 2023-06 | Divested | 2 |
| HHI divestiture to ASSA ABLOY | 2023-05 | Divested | 3 |
| Tristar Business product disposal | 2023 | Divested | 8 |
| Sale of HHI business | 2023 | Divested | 7 |
| ASSA ABLOY Divestiture of Emtek and Smart Residential Business | 2022-12 | Divested | 1 |
| HHI Segment Divestiture to ASSA ABLOY | 2021-09 | Divested | 1 |
| Coevorden dog and cat food facility sale | 2020-03 | Divested | 3 |
| Coevorden Netherlands dog/cat food facility divestiture to United Petfood Producers NV | 2020-03 | Divested | 8 |
| Coevorden DCF Facility Divestiture | 2020-03 | Divested | 1 |
| Global Appliances business creation | – | Divested | 16 |
Reported KPIs (as disclosed) (209)#
Figures the company discloses itself in addition to the standard financials; order intake, recurring revenue, user or unit counts, adjusted measures. These “story KPIs” usually slip through standard databases; here they are collected as reported, with no calculation of our own. Important: the definition comes from the company itself and can differ from firm to firm; period and source are stated next to every value.
| Date | Period | KPI | Value / change | Source |
|---|---|---|---|---|
| 2026-08-07 | 2026-Q3 | total liquidity | $753.7 | 29 |
| 2026-08-07 | 2026-Q3 | cash and cash equivalents | $258.9 | 29 |
| 2026-08-07 | 2026-Q3 | borrowing availability | $494.8 | 29 |
| 2026-08-07 | 2026-Q3 | Total Liquidity | 753.7 | 30 |
| 2026-08-07 | 2026-Q3 | Net Debt Leverage | 1.02x Adjusted EBITDA | 30 |
| 2026-08-07 | 2026-Q3 | Net Debt | 374.1 (USD in millions) | 30 |
| 2026-08-07 | 2026-Q3 | Cash and Cash Equivalents | 258.9 (USD in millions) | 30 |
| 2026-05-07 | 2026-Q2 | total liquidity | 595.9 | 27 |
| 2026-05-07 | 2026-Q2 | cash and equivalents | 125.1 (USD in millions) | 27 |
| 2026-05-07 | 2026-Q2 | borrowing availability | 470.8 | 27 |
| 2026-05-07 | 2026-Q2 | Undrawn capacity on cash flow revolver | 470.8 (USD in millions) | 28 |
| 2026-05-07 | 2026-Q2 | Total liquidity | 595.9 | 28 |
| 2026-05-07 | 2026-Q2 | Total debt outstanding | 599.7 (USD in millions) | 28 |
| 2026-05-07 | 2026-Q2 | Net debt | 474.6 (USD in millions) | 28 |
| 2026-05-07 | 2026-Q2 | Net Debt Leverage | 1.66x | 28 |
| 2026-05-07 | 2026-Q2 | Cash and cash equivalents | 125.1 (USD in millions) | 28 |
| 2026-02-05 | 2026-Q1 | total liquidity | 618.8 | 25 |
| 2026-02-05 | 2026-Q1 | cash and equivalents | 126.6 (USD in millions) | 25 |
| 2026-02-05 | 2026-Q1 | borrowing availability | 492.2 | 25 |
| 2026-02-05 | 2026-Q1 | Total Liquidity | 618.8 | 26 |
| 2026-02-05 | 2026-Q1 | Total Debt Outstanding | 578.9 (USD in millions) | 26 |
| 2026-02-05 | 2026-Q1 | Share Repurchases | 0.6 million shares for $36 million | 26 |
| 2026-02-05 | 2026-Q1 | Net Debt Leverage | 1.65x | 26 |
| 2026-02-05 | 2026-Q1 | Net Debt | 452.3 (USD in millions) | 26 |
| 2026-02-05 | 2026-Q1 | Cash Balance | 126.6 (USD in millions) | 26 |
| 2025-11-18 | FY2025 | Valuation allowance | 296.4 | 24 |
| 2025-11-18 | FY2025 | Unrecognized tax benefits | 112.5 | 24 |
| 2025-11-18 | FY2025 | Total liquidity | 615.9 | 24 |
| 2025-11-18 | FY2025 | Operating cash flow | 204.1 (USD in millions) | 24 |
| 2025-11-18 | FY2025 | Investing cash flow | -37.7 (USD in millions) | 24 |
| 2025-11-18 | FY2025 | HPC net sales | 1,153.7 (USD in millions, except %) | 24 |
| 2025-11-18 | FY2025 | HG net sales | 572.8 (USD in millions, except %) | 24 |
| 2025-11-18 | FY2025 | Gross Profit Margin (prior year) | 37.4% | 24 |
| 2025-11-18 | FY2025 | Gross Profit Margin | 36.7% | 24 |
| 2025-11-18 | FY2025 | GPC net sales | 1,082.5 (USD in millions, except %) | 24 |
| 2025-11-18 | FY2025 | Foreign currency debt | 8.1 (USD in millions equivalent) | 24 |
| 2025-11-18 | FY2025 | Financing cash flow | -401.2 (USD in millions) | 24 |
| 2025-11-18 | FY2025 | Federal NOLs | 601.8 | 24 |
| 2025-11-18 | FY2025 | Cash and cash equivalents | 123.6 (USD in millions) | 24 |
| 2025-11-18 | FY2025 | Borrowing availability | 492.3 | 24 |
| 2025-11-18 | FY2025 | Adjusted EBITDA margin (prior year) | 12.5% | 24 |
| 2025-11-18 | FY2025 | Adjusted EBITDA margin | 10.3% | 24 |
| 2025-11-13 | 2025-Q4 | Total Liquidity | 615.9 | 23 |
| 2025-11-13 | 2025-Q4 | Total Debt Outstanding | 581.4 (USD millions) | 23 |
| 2025-11-13 | 2025-Q4 | Net Debt Leverage | 1.58x | 23 |
| 2025-11-13 | 2025-Q4 | Net Debt | 457.8 (USD millions) | 23 |
| 2025-11-13 | 2025-Q4 | Cash and Cash Equivalents | 123.6 (USD millions) | 23 |
| 2025-08-07 | 2025-Q3 | Undrawn revolver capacity | 388.5 | 22 |
| 2025-08-07 | 2025-Q3 | total liquidity | 510.5 | 22 |
| 2025-08-07 | 2025-Q3 | Total debt outstanding | 681.1 (USD in millions) | 22 |
| 2025-08-07 | 2025-Q3 | Shares repurchased Q3 | 0.9 million | 22 |
| 2025-08-07 | 2025-Q3 | shares outstanding | 24.2 million | 22 |
| 2025-08-07 | 2025-Q3 | senior unsecured notes | 496.1 | 22 |
| 2025-08-07 | 2025-Q3 | revolver borrowings | 103.0 | 22 |
| 2025-08-07 | 2025-Q3 | repurchase cost Q3 | 54.4 (USD in millions) | 22 |
| 2025-08-07 | 2025-Q3 | net debt | 559.1 (USD in millions) | 22 |
| 2025-08-07 | 2025-Q3 | finance leases | 82.0 | 22 |
| 2025-08-07 | 2025-Q3 | cumulative shares repurchased since HHI divestiture | 17.1 million | 22 |
| 2025-08-07 | 2025-Q3 | cumulative repurchase cost since HHI divestiture | 1.3 billion | 22 |
| 2025-08-07 | 2025-Q3 | cash balance | 122.0 (USD in millions) | 22 |
| 2025-08-07 | 2025-Q3 | Total liquidity | 510.5 | 21 |
| 2025-08-07 | 2025-Q3 | net sales | 699.6 (USD in millions) | 21 |
| 2025-08-07 | 2025-Q3 | net income from continuing operations | 20.5 | 21 |
| 2025-08-07 | 2025-Q3 | interest expense | 8.4 (USD in millions) | 21 |
| 2025-08-07 | 2025-Q3 | gross profit margin | 37.8% | 21 |
| 2025-08-07 | 2025-Q3 | Cash and cash equivalents | 122.0 (USD in millions) | 21 |
| 2025-08-07 | 2025-Q3 | Borrowing availability | 388.5 | 21 |
| 2025-05-08 | 2025-Q2 | Total liquidity | 504.6 | 19 |
| 2025-05-08 | 2025-Q2 | Total Liquidity | 504.6 | 20 |
| 2025-05-08 | 2025-Q2 | Total Debt Outstanding | 656.9 (USD in millions) | 20 |
| 2025-05-08 | 2025-Q2 | Net Debt | 560.9 (USD in millions) | 20 |
| 2025-05-08 | 2025-Q2 | gross profit margin (six months) | 37.2% | 19 |
| 2025-05-08 | 2025-Q2 | gross profit margin (six months prior year) | 36.7% | 19 |
| 2025-05-08 | 2025-Q2 | gross profit margin (prior year Q2) | 38.1% | 19 |
| 2025-05-08 | 2025-Q2 | gross profit margin | 37.5% | 19 |
| 2025-05-08 | 2025-Q2 | Cash and cash equivalents | 96.0 (USD in millions) | 19 |
| 2025-05-08 | 2025-Q2 | Cash Balance | 96.0 (USD in millions) | 20 |
| 2025-05-08 | 2025-Q2 | Borrowing availability | 408.6 | 19 |
| 2025-05-08 | 2025-Q2 | adjusted EBITDA margin (six months) | 10.8% | 19 |
| 2025-05-08 | 2025-Q2 | adjusted EBITDA margin (six months prior year) | 13.9% | 19 |
| 2025-05-08 | 2025-Q2 | adjusted EBITDA margin (prior year Q2) | 15.6% | 19 |
| 2025-05-08 | 2025-Q2 | Adjusted EBITDA margin | 10.6% | 19 |
| 2025-02-06 | 2025-Q1 | Total Liquidity | 670.7 | 18 |
| 2025-02-06 | 2025-Q1 | target long-term net leverage ratio | 2.0 - 2.5 times | 18 |
| 2025-02-06 | 2025-Q1 | Net income from continuing operations margin | 3.5% | 17 |
| 2025-02-06 | 2025-Q1 | Net Debt | 395.2 (USD in millions) | 18 |
| 2025-02-06 | 2025-Q1 | gross profit margin | 36.8% | 17 |
| 2025-02-06 | 2025-Q1 | Debt Outstanding | 575.1 (USD in millions) | 18 |
| 2025-02-06 | 2025-Q1 | Cash Balance | 180 (USD in millions) | 18 |
| 2024-11-15 | FY2024 | Unrecognized tax benefits | 108.5 | 15 |
| 2024-11-15 | FY2024 | US federal NOL carryforwards | 569.2 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | US deferred tax valuation allowance | 203.6 | 15 |
| 2024-11-15 | FY2024 | Total valuation allowance | 321.4 | 15 |
| 2024-11-15 | FY2024 | Total selling general administrative | 958.5 | 15 |
| 2024-11-15 | FY2024 | Total liquidity | 859.7 | 15 |
| 2024-11-15 | FY2024 | Strategic transaction restructuring optimization | 33.7 | 15 |
| 2024-11-15 | FY2024 | State NOL future tax benefits | 42.8 | 15 |
| 2024-11-15 | FY2024 | Sales marketing advertising | 346.6 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | Research development | 28.1 | 15 |
| 2024-11-15 | FY2024 | Representation Warranty Insurance gain | 65.0 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | Projected repatriation tax | 1.7 | 15 |
| 2024-11-15 | FY2024 | Prior year net income from continuing operations margin | -8.0% | 15 |
| 2024-11-15 | FY2024 | Prior year gross profit margin | 31.7% | 15 |
| 2024-11-15 | FY2024 | Prior year Adjusted EBITDA margin | 9.4% | 15 |
| 2024-11-15 | FY2024 | Operating cash flow prior year | 8.0 (USD in millions) | 15 |
| 2024-11-15 | FY2024 | Operating cash flow continuing | 269.8 (USD in millions) | 15 |
| 2024-11-15 | FY2024 | Net income from continuing operations margin | 3.4% | 15 |
| 2024-11-15 | FY2024 | Net FX impact after underlying exposures | 11.8 | 15 |
| 2024-11-15 | FY2024 | Mandatory repatriation tax liability | 11.1 | 15 |
| 2024-11-15 | FY2024 | Impairment Rejuvenate OmegaSea tradenames | 45.2 | 15 |
| 2024-11-15 | FY2024 | gross profit margin | 37.4% | 15 |
| 2024-11-15 | FY2024 | General administrative | 283.2 | 15 |
| 2024-11-15 | FY2024 | Foreign deferred tax valuation allowance | 117.8 | 15 |
| 2024-11-15 | FY2024 | Federal tax benefit NOL | 119.5 | 15 |
| 2024-11-15 | FY2024 | FX derivative loss 10pct unfavorable | 86.3 | 15 |
| 2024-11-15 | FY2024 | Exchangeable Notes issued | 350.0 | 15 |
| 2024-11-15 | FY2024 | Domestic valuation allowance unreleased | 131.7 | 15 |
| 2024-11-15 | FY2024 | Distribution | 266.9 | 15 |
| 2024-11-15 | FY2024 | Debt paid down | 1,349.3 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | Debt foreign currencies | 7.0 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | Common stock repurchase | 482.7 | 15 |
| 2024-11-15 | FY2024 | Cash and cash equivalents | 368.9 (USD in millions, except %) | 15 |
| 2024-11-15 | FY2024 | Borrowing availability credit facility | 490.8 | 15 |
| 2024-11-15 | FY2024 | Annual interest payments | 22.1 | 15 |
| 2024-11-15 | FY2024 | Adjusted EBITDA margin | 12.5% | 15 |
| 2024-11-15 | 2024-Q4 | Total Liquidity | 860 | 16 |
| 2024-11-15 | 2024-Q4 | Total Debt Outstanding | 578 (USD in millions) | 16 |
| 2024-11-15 | 2024-Q4 | Net Debt Leverage | 0.56x | 16 |
| 2024-11-15 | 2024-Q4 | Net Debt | 209 (USD in millions) | 16 |
| 2024-11-15 | 2024-Q4 | Cash Balance | 369 (USD in millions) | 16 |
| 2024-08-08 | 2024-Q3 | Total liquidity | 797 | 14 |
| 2024-08-08 | 2024-Q3 | Operating cash flow | 178.4 (USD in millions) | 13 |
| 2024-08-08 | 2024-Q3 | Net debt | 272 (USD in millions) | 14 |
| 2024-08-08 | 2024-Q3 | E-commerce sales pct | over 21% | 14 |
| 2024-08-08 | 2024-Q3 | Available borrowing capacity | 490.4 | 13 |
| 2024-08-08 | 2024-Q3 | Adjusted EBITDA margin - HPC | 4.1% | 13 |
| 2024-08-08 | 2024-Q3 | Adjusted EBITDA margin - H&G | 20.5% | 13 |
| 2024-08-08 | 2024-Q3 | Adjusted EBITDA margin - GPC | 20.1% | 13 |
| 2024-08-08 | 2024-Q3 | Adjusted EBITDA margin - Consolidated | 13.6% | 13 |
| 2024-05-09 | 2024-Q2 | Total debt outstanding | 1,401 (USD millions) | 12 |
| 2024-05-09 | 2024-Q2 | Short-term investments | 500 (USD millions) | 12 |
| 2024-05-09 | 2024-Q2 | SBH Rule 10b5 1 repurchases YTD | 108.7 million | 11 |
| 2024-05-09 | 2024-Q2 | Net income margin | 6.9 | 12 |
| 2024-05-09 | 2024-Q2 | Net debt | 155 (USD millions) | 12 |
| 2024-05-09 | 2024-Q2 | HPC Adjusted EBITDA margin 6M 2024 | 7.3 % | 11 |
| 2024-05-09 | 2024-Q2 | HPC Adjusted EBITDA margin 6M 2023 | 1.8 % | 11 |
| 2024-05-09 | 2024-Q2 | HPC Adjusted EBITDA margin 3M 2024 | 6.6 % | 11 |
| 2024-05-09 | 2024-Q2 | HPC Adjusted EBITDA margin 3M 2023 | -0.7 % | 11 |
| 2024-05-09 | 2024-Q2 | H&G Adjusted EBITDA margin 6M 2024 | 12.2 % | 11 |
| 2024-05-09 | 2024-Q2 | H&G Adjusted EBITDA margin 6M 2023 | 5.7 % | 11 |
| 2024-05-09 | 2024-Q2 | H&G Adjusted EBITDA margin 3M 2024 | 18.2 % | 11 |
| 2024-05-09 | 2024-Q2 | H&G Adjusted EBITDA margin 3M 2023 | 9.8 % | 11 |
| 2024-05-09 | 2024-Q2 | gross profit margin | 38.1 | 12 |
| 2024-05-09 | 2024-Q2 | Gross Profit Margin 6M 2024 | 36.7 % | 11 |
| 2024-05-09 | 2024-Q2 | Gross Profit Margin 6M 2023 | 28.9 % | 11 |
| 2024-05-09 | 2024-Q2 | Gross Profit Margin 3M 2024 | 38.1 % | 11 |
| 2024-05-09 | 2024-Q2 | Gross Profit Margin 3M 2023 | 29.4 % | 11 |
| 2024-05-09 | 2024-Q2 | GPC Adjusted EBITDA margin 6M 2024 | 20.3 % | 11 |
| 2024-05-09 | 2024-Q2 | GPC Adjusted EBITDA margin 6M 2023 | 14.5 % | 11 |
| 2024-05-09 | 2024-Q2 | GPC Adjusted EBITDA margin 3M 2024 | 21.5 % | 11 |
| 2024-05-09 | 2024-Q2 | GPC Adjusted EBITDA margin 3M 2023 | 15.6 % | 11 |
| 2024-05-09 | 2024-Q2 | Cash balance | 746 (USD millions) | 12 |
| 2024-05-09 | 2024-Q2 | Borrowing availability | 490.3 million | 11 |
| 2024-05-09 | 2024-Q2 | Adjusted EBITDA margin 6M 2024 | 13.9 % | 11 |
| 2024-05-09 | 2024-Q2 | Adjusted EBITDA margin 6M 2023 | 6.3 % | 11 |
| 2024-05-09 | 2024-Q2 | Adjusted EBITDA margin 3M 2024 | 15.6 % | 11 |
| 2024-05-09 | 2024-Q2 | Adjusted EBITDA margin 3M 2023 | 7.0 % | 11 |
| 2024-05-09 | 2024-Q2 | Adjusted EBITDA margin (excluding investment income) | 13.3 | 12 |
| 2024-02-08 | 2024-Q1 | borrowing availability | 486.9 million | 9 |
| 2024-02-08 | 2024-Q1 | Total debt outstanding | 1,415 million | 10 |
| 2024-02-08 | 2024-Q1 | Short-term investments | 950 million | 10 |
| 2024-02-08 | 2024-Q1 | Net debt | 19 million | 10 |
| 2024-02-08 | 2024-Q1 | Cash and cash equivalents | 445 million | 10 |
| 2023-11-21 | FY2023 | Adjusted EBITDA Margin HPC | 3.5 % | 8 |
| 2023-11-21 | FY2023 | Adjusted EBITDA Margin H&G | 13.5 % | 8 |
| 2023-11-21 | FY2023 | Adjusted EBITDA Margin Consolidated | 10.4 % | 8 |
| 2023-11-21 | FY2023 | Adjusted EBITDA Margin | 16.7 % | 8 |
| 2023-11-17 | 2023-Q4 | Total debt | 1,574 (USD in millions) | 7 |
| 2023-11-17 | 2023-Q4 | Short-term investments | 1,103.3 (USD in millions) | 7 |
| 2023-11-17 | 2023-Q4 | Net cash position | positive | 7 |
| 2023-11-17 | 2023-Q4 | Cash and cash equivalents | 753.9 (USD in millions) | 7 |
| 2023-08-11 | 2023-Q3 | Organic net sales decrease (three months) | 9.7% | 6 |
| 2023-08-11 | 2023-Q3 | Organic net sales decrease (nine months) | 9.8% | 6 |
| 2023-08-11 | 2023-Q3 | Organic net sales - Total | (9.7)% | 5 |
| 2023-08-11 | 2023-Q3 | Organic net sales - HPC | (14.7)% | 5 |
| 2023-08-11 | 2023-Q3 | Organic net sales - H&G | (6.0)% | 5 |
| 2023-08-11 | 2023-Q3 | Organic net sales - GPC | (6.4)% | 5 |
| 2023-08-11 | 2023-Q3 | Net cash position | 2.9 billion cash and 2.1 billion debt | 6 |
| 2023-08-11 | 2023-Q3 | Debt outstanding | 2,101 (USD in millions) | 6 |
| 2023-08-11 | 2023-Q3 | Cash and cash equivalents | 2,930.2 (USD in millions) | 6 |
| 2023-08-11 | 2023-Q3 | Adjusted EBITDA margin - HPC | 4.1% | 5 |
| 2023-08-11 | 2023-Q3 | Adjusted EBITDA margin - H&G | 20.7% | 5 |
| 2023-08-11 | 2023-Q3 | Adjusted EBITDA margin - GPC | 19.7% | 5 |
| 2023-08-11 | 2023-Q3 | Adjusted EBITDA margin - Consolidated | 13.4% | 5 |
| 2023-05-12 | 2023-Q2 | Total debt outstanding | 3,222 million | 4 |
| 2023-05-12 | 2023-Q2 | Proforma net leverage | 6.3 times | 4 |
| 2023-05-12 | 2023-Q2 | Long-term net leverage target | 2.0 - 2.5 times | 4 |
| 2023-05-12 | 2023-Q2 | Cash balance | 328 million | 4 |
| 2023-05-12 | 2023-Q2 | Adjusted EBITDA margin | 7.0% | 3 |
| 2023-02-10 | 2023-Q1 | Total debt outstanding | 3,315 (USD millions) | 2 |
| 2023-02-10 | 2023-Q1 | Target net leverage long term | 2.0 - 2.5 | 2 |
| 2023-02-10 | 2023-Q1 | net leverage proforma | 6.2 | 2 |
| 2023-02-10 | 2023-Q1 | expected HHI sale proceeds | 4.3 (USD billions) | 2 |
| 2023-02-10 | 2023-Q1 | cash balance | 228 (USD millions) | 2 |
| 2023-02-10 | 2023-Q1 | Borrowing availability | 252.5 million | 1 |
| 2023-02-10 | 2023-Q1 | Adjusted EBITDA margin HPC | 3.6% | 1 |
| 2023-02-10 | 2023-Q1 | Adjusted EBITDA margin H&G | (3.4)% | 1 |
| 2023-02-10 | 2023-Q1 | Adjusted EBITDA margin GPC | 13.4% | 1 |
| 2023-02-10 | 2023-Q1 | Adjusted EBITDA margin | 5.6% | 1 |
Guidance Tracking (latest per metric/period · 8/12)#
All management forecasts (guidance) and their later outcome. Types: fiscal-year targets as well as quarterly/half-year targets; per metric and period the most recent statement applies, older versions can be expanded. The status is checked automatically against the actuals reported later: open (period still running), met, beaten, missed. For ranges (“X to Y”) reaching the range counts. Logged neutrally, no estimate of our own, no assessment.
Actuals: revenue in $m · ratios in %
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | 2026-08-07 | Revenue | Flat to Up Low Single Digits | – | pending | confirmed | 30 |
| FY2026 | 2026-08-07 | EBITDA (adjusted) | Up Mid Single Digits | – | pending | raised | 30 |
| FY2026 | 2026-02-05 | Adjusted Free Cash Flow | ~50% | – | pending | confirmed | 30 |
| FY2026 | 2025-11-13 | Adjusted Free Cash Flow Conversion | ~50% | – | pending | confirmed | 23 |
| FY2025 | 2025-05-08 | Free Cash Flow | ~160 | – | – | confirmed | 22 |
| FY2025 | 2025-02-06 | Revenue | low single-digit growth | 2,809 | – | confirmed | 18 |
| FY2025 | 2025-02-06 | EBITDA (adjusted) | mid to high single-digits | 289.1 | – | confirmed | 18 |
| FY2025 | 2024-11-15 | Adjusted Free Cash Flow | ~50% | – | – | confirmed | 18 |
| FY2024 | 2024-08-08 | Revenue | Relatively flat compared to Fiscal 2023 | 2,963.9 | – | confirmed | 14 |
| FY2024 | 2024-08-08 | EBITDA (adjusted) | ~20% | 371.8 | – | raised | 14 |
| FY2023 | 2023-08-11 | Revenue | decline by mid single-digits | 2,918.8 | – | confirmed | 6 |
| FY2023 | 2023-08-11 | EBITDA (adjusted) | decline by low to mid single-digits | 303.6 | – | confirmed | 6 |
Development#
A condensed summary per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. Most recent period first, grouped by year; each text is written from the original report of that period, superscript numbers lead to the source.
FY2026
In fiscal year 2026, Spectrum Brands Holdings reported a progressive top-line recovery across the three quarters ended July 2026, with nine-month consolidated net sales of $2,139.2 million, up 3.1% year-over-year (29). The first quarter recorded consolidated net sales of $677.0 million, a 3.3% decline with organic net sales down 6.0%, driven by volume declines in H&G and HPC and tariff-related cost pressures, while adjusted EBITDA margin compressed 200 basis points to 9.2% (25). In Q2, consolidated net sales recovered to $708.9 million (+4.9%), marking the first top-line growth since Q1 fiscal 2025, and Spectrum Brands executed a $127 million strategic investment by Oaktree Capital Management in the Home & Personal Care business, with Oaktree acquiring a 24.9% equity stake (28). Q3 net sales rose 7.7% to $753.3 million with organic growth of 6.6%, and adjusted EBITDA more than doubled to $158.3 million, including $60.6 million in one-time IEEPA tariff refunds following a court ruling on their unlawfulness; concurrently, a $104.0 million impairment charge on HPC indefinite-lived intangible assets produced a Q3 net loss of $26.8 million (29). By Q3, the company raised its fiscal 2026 adjusted EBITDA outlook to mid single-digit growth, up from the flat-to-low single-digit framework in place at the start of the year (30).
FY2025
Spectrum Brands Holdings reported FY2025 net sales of $2,809.0 million, a decrease of 5.2% versus the prior year, as volume declines across all three segments – Global Pet Care, Home and Garden, and Home and Personal Care – were compounded by tariff-related supply constraints and softening consumer demand 24. Full-year adjusted EBITDA declined 22.2% to $289.1 million, compressing adjusted EBITDA margin from 12.5% to 10.3%, while gross profit margin contracted 70 basis points to 36.7%, driven by lower volumes, incremental tariffs, and unfavorable product mix 24. The company temporarily paused finished goods imports from China in early calendar 2025 and subsequently diversified its supply chain, with the Home and Personal Care segment most significantly affected given that over 60% of its sales are derived from international markets 24. Adjusted free cash flow for the full year reached $170.7 million, exceeding the communicated $160 million target, and net debt leverage ended at 1.58x adjusted EBITDA, below the long-term target range of 2.0–2.5x 23. In conjunction with full-year results, the company announced a plan to divest the Home and Personal Care business through a sale or spin-off to create two distinct publicly traded companies 24.
FY2024
In fiscal year 2024, Spectrum Brands Holdings net sales rose 1.5% to $2,963.9 million with organic growth of 1.5%, as Home & Garden segment growth of 7.8% organically offset a modest organic decline in Home & Personal Care (−0.3%) and near-flat Global Pet Care (+0.4% organically) 15. Gross profit margin expanded to 37.4% from 31.7%, driven primarily by lower cost inventory entering the year compared to the prior-year period and improved volume 15. Adjusted EBITDA grew 35.2% to $371.8 million, with margin improvements across all three segments, and the company recognized a $65.0 million gain from representation and warranty insurance proceeds related to the Tristar Business acquisition 15. The company repaid $1,349.3 million of senior notes, issued $350.0 million in 3.375% Exchangeable Senior Notes, and ended fiscal 2024 at net debt leverage of 0.56x adjusted EBITDA with total liquidity of $860 million 15 16. Spectrum Brands filed a confidential Form 10 registration statement to pursue the strategic separation of the Home & Personal Care segment and returned $482.7 million to shareholders through share repurchases during the fiscal year 15 16.
FY2023
Spectrum Brands Holdings reported FY2023 consolidated net sales of $2,918.8 million, a decline of 6.8% year over year, as lower volumes across the Global Pet Care, Home and Garden, and Home and Personal Care segments outweighed modest pricing gains, with headwinds from retailer inventory destocking and unfavorable foreign currency throughout the year 8. The full-year operating loss of $205.6 million was substantially driven by $111.1 million in goodwill impairment in the Home and Personal Care reporting unit and $120.7 million in intangible asset impairments, including the Rejuvenate, PowerXL, and George Foreman tradenames 8. The defining corporate event of the fiscal year was the June 20, 2023 completion of the Hardware and Home Improvement segment divestiture to ASSA ABLOY AB for $4.3 billion in cash, which generated a gain of approximately $2.8 billion and drove reported full-year net income of $1,801.9 million 5 8. Post-divestiture proceeds funded repayment of over $1.5 billion in outstanding debt and a $534.7 million share repurchase program via an accelerated share repurchase agreement and open market purchases 8. Fourth-quarter adjusted EBITDA of $113.7 million was the highest quarterly figure of the fiscal year, supported by gross profit improvements, exit of non-core unproductive categories, and interest income on post-divestiture cash balances 7.
Sources: official investor relations documents#
All original documents used, with type (e.g. quarterly, half-year, annual report), publication date and a direct link to the filing (EDINET/SEC/IR). Every superscript number in the report points to an entry in this list; so every figure can be traced back to its place in the original.
| # | Document type | Published | Link |
|---|---|---|---|
| #1 | 10-Q | 2023-02-10 | Open |
| #2 / #102 | 8-K-EX99.1 | 2023-02-10 | Open |
| #3 | 10-Q | 2023-05-12 | Open |
| #4 / #104 | 8-K-EX99.1 | 2023-05-12 | Open |
| #5 | 10-Q | 2023-08-11 | Open |
| #6 / #106 | 8-K-EX99.1 | 2023-08-11 | Open |
| #7 / #107 | 8-K-EX99.1 | 2023-11-17 | Open |
| #8 | 10-K | 2023-11-21 | Open |
| #9 | 10-Q | 2024-02-08 | Open |
| #10 / #110 | 8-K-EX99.1 | 2024-02-08 | Open |
| #11 | 10-Q | 2024-05-09 | Open |
| #12 / #112 | 8-K-EX99.1 | 2024-05-09 | Open |
| #13 | 10-Q | 2024-08-08 | Open |
| #14 / #114 | 8-K-EX99.1 | 2024-08-08 | Open |
| #15 | 10-K | 2024-11-15 | Open |
| #16 / #116 | 8-K-EX99.1 | 2024-11-15 | Open |
| #17 | 10-Q | 2025-02-06 | Open |
| #18 / #118 | 8-K-EX99.1 | 2025-02-06 | Open |
| #19 | 10-Q | 2025-05-08 | Open |
| #20 / #120 | 8-K-EX99.1 | 2025-05-08 | Open |
| #21 | 10-Q | 2025-08-07 | Open |
| #22 / #122 | 8-K-EX99.1 | 2025-08-07 | Open |
| #23 / #123 | 8-K-EX99.1 | 2025-11-13 | Open |
| #24 | 10-K | 2025-11-18 | Open |
| #25 | 10-Q | 2026-02-05 | Open |
| #26 / #126 | 8-K-EX99.1 | 2026-02-05 | Open |
| #27 | 10-Q | 2026-05-07 | Open |
| #28 / #128 | 8-K-EX99.1 | 2026-05-07 | Open |
| #29 | 10-Q | 2026-08-07 | Open |
| #30 / #130 | 8-K-EX99.1 | 2026-08-07 | Open |
Older sources (+18)
| # | Document type | Published | Link |
|---|---|---|---|
| #201 | 10-Q | 2016-05-09 | Open |
| #202 | 8-K | 2016-08-09 | Open |
| #206 | 8-K | 2016-11-23 | Open |
| #203 | 10-Q | 2017-05-05 | Open |
| #205 | 10-K | 2017-08-04 | Open |
| #208 | 10-K | 2017-11-20 | Open |
| #207 | 10-Q | 2018-05-04 | Open |
| #204 | 10-Q | 2018-08-08 | Open |
| #212 | 10-K | 2018-11-23 | Open |
| #209 | 10-Q | 2019-02-07 | Open |
| #210 | 10-Q | 2019-05-08 | Open |
| #214 | 10-K | 2020-02-04 | Open |
| #213 | 10-Q | 2020-05-05 | Open |
| #211 | 10-Q | 2020-07-31 | Open |
| #218 | 10-K | 2020-11-18 | Open |
| #215 | 10-Q | 2021-02-05 | Open |
| #216 | 10-Q | 2021-05-07 | Open |
| #217 | 10-Q | 2021-08-06 | Open |
FAQ#
Is there a management forecast (guidance) for FY2026?
Yes. Management has issued targets for FY2026, including Revenue. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Where can I find the official investor relations documents of Spectrum Brands Holdings Inc.?
The sources chapter links all 63 original filings used (SEC filings) with type, publication date and a direct link; every figure in the report carries a source number.